Athira Pharma to Host Educational Webinar on the Clinical Applications of ERP P300
Neurologist Dr. John Michael Olichney to discuss utility of P300 to assess cognitive function Webinar to be held Friday, Nov....
Month: October 2021
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction
FREEDOM-2 trial will evaluate the potential for the company’s investigational allogeneic cell therapy, FCR001, to induce durable immune tolerance in...
Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update
BERKELEY HEIGHTS, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a...
PLx Pharma Inc. Provides VAZALORE Launch Update
-- Supplied VAZALORE to 30,000+ stores nationwide and e-commerce sites -- -- Launch in line with expectations and exceptionally positive...
On the final termination of legal proceedings related to the mandatory repurchase offer of AS “Olainfarm”
The Supreme Court has rejected an ancillary complaint by the minority shareholders of AS Olainfarm regarding the decision of the...
The UroLift® System Receives Bronze Award for Best New Branded Television Campaign and Honorable Mention in the Best Branded Website Category from DTC Perspectives
WAYNE, Pa., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that the UroLift® System was honored...
Affimed to Report Third Quarter 2021 Financial Results & Corporate Update on November 10, 2021
HEIDELBERG, Germany, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving...
Aino Health AB (publ): Aino Health interim report January-September 2021
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original...
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021 Message from the CEO As is well known, IBT...
Valneva announces temporary trading suspension of its ordinary shares on Euronext Paris
Saint-Herblain (France), October 29, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”), a specialty vaccine company, announces...
Nexstim Receives an NBS System Order from a Hospital in Europe
Press release, Helsinki, 29 October 2021 at 9 AM (EEST) Nexstim Receives an NBS System Order from a Hospital in...
IMPACT trial data shows clear benefit in using Roche’s CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer
IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk...
EssilorLuxottica : EssilorLuxottica’s third-quarter 2021 revenue / Keeping the pace of a fast recovery at +9% / Full year outlook upgraded again and GrandVision consolidation
EssilorLuxottica’s third-quarter 2021 revenue Keeping the pace of a fast recovery at +9% Full year outlook upgraded again and GrandVision...
Valneva Announces the Pricing of its Global Offering of American Depositary Shares and Ordinary Shares
Saint-Herblain (France), October 29, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”), a specialty vaccine company, announced...
Interim Report Q3 2021: In Q3 2021, GN Store Nord delivered 2% organic revenue growth and announced the acquisition of SteelSeries. Revision of GN Audio’s organic revenue growth guidance
- - GN Store Nord GN delivered 2% organic revenue growth in Q3 2021 – building off a very strong...
Mergen Orthodontics Clear Solutions Preventive Care Program Released.
Mergen Orthodontics has exceeded everyone's expectations by publishing a brand new video entitled "Mergen Orthodontics Transforming Over 22,000 Smiles in...
Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives...
Biofrontera Inc. Announces Pricing of $18.0 Million Initial Public Offering
WOBURN, MA. , Oct. 28, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (“Biofrontera” or the “Company”) (Nasdaq: BFRI; BFRIW), a biopharmaceutical...
4D Molecular Therapeutics Announces Pricing of Public Offering of Common Stock
EMERYVILLE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing...
Veris Health Showcased in PAVmed Digital Health Virtual Investor Event
Panelists discussed Veris’ vision and strategy to transform cancer care and join the current digital health revolution NEW YORK--(BUSINESS WIRE)--$PAVM--PAVmed...
